A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
NCT00458146 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2008-03-27
Summary
The purpose of this study is to determine whether MM-093 is safe and effective in the treatment of RA.
Conditions
Interventions
- DRUG
-
MM-093
60mg MM-093/week as a subcutaneous injection for 3 months
Sponsors & Collaborators
-
Merrimack Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
Study Evaluating TMI-005 in Active Rheumatoid Arthritis
NCT00095342 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
NCT00928512 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
NCT00299104 ·Status: COMPLETED ·Phase: PHASE3
-
Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients
NCT00669942 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00264550 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)
NCT01569152 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis
NCT01975610 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
NCT00808210 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
NCT00838565 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
NCT06671054 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
NCT03660059 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
NCT00105976 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis
NCT00941707 ·Status: TERMINATED ·Phase: PHASE2
-
BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis
NCT00458861 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis
NCT02784106 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA
NCT04247815 ·Status: COMPLETED ·Phase: PHASE2
-
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00095147 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
NCT00264537 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00361335 ·Status: COMPLETED ·Phase: PHASE3
-
Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate
NCT00628095 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
NCT00485589 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate
NCT02698657 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
NCT02222493 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
NCT02760407 ·Status: COMPLETED ·Phase: PHASE3